CCM 📈 Concord Medical Services - Overview
Exchange: NYSE • Country: China • Currency: USD • Type: Common Stock • ISIN: US2062771058
CCM: Cancer, Radiotherapy, Imaging, Equipment, Hospitals, Diagnostics, Research
Concord Medical Services Holdings Limited, through its subsidiaries, operates a network of radiotherapy and diagnostic imaging centers in the People's Republic of China. It operates in two segments, Network and Hospital. The company's services include linear accelerators and external beam radiotherapy, proton therapy system, gamma knife radiosurgery, and diagnostic imaging services. Its other treatments and diagnostic services comprise positron emission tomography-computed tomography and magnetic resonance imaging scanners. In addition, the company provides clinical support services, such as developing treatment protocols for doctors, and organizing joint diagnosis between doctors in its network and clinical research, as well as helps to recruit and determine the compensation of doctors and other medical personnel. Further, it offers radiotherapy and diagnostic equipment leasing, management services, and premium cancer and proton treatment services to hospitals, as well as teleconsultation and medical information technology services; and sells medical equipment. Additionally, the company operates specialty cancer hospitals, which offers radiation, imaging, test laboratory, inpatient, and nursing services. Concord Medical Services Holdings Limited was founded in 1997 and is headquartered in Beijing, the People's Republic of China. Web URL: https://www.concordmedical.com
Additional Sources for CCM Stock
News:
Wall Street Journal
Benzinga
Yahoo Finance
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
CCM Stock Overview
| Market Cap in USD | 21m |
| Sector | Healthcare |
| Industry | Medical Care Facilities |
| GiC Sub-Industry | Health Care Services |
| IPO / Inception | 2009-12-11 |
CCM Stock Ratings
| Growth 5y | -83.8% |
| Fundamental | -65.6% |
| Dividend | 1.41% |
| Rel. Strength Industry | -1242 |
| Analysts | - |
| Fair Price Momentum | 3.14 USD |
| Fair Price DCF | - |
CCM Dividends
| Dividend Yield 12m | 0.00% |
| Yield on Cost 5y | % |
| Annual Growth 5y | 0.00% |
| Payout Consistency | 4.7% |
CCM Growth Ratios
| Growth Correlation 3m | -73.5% |
| Growth Correlation 12m | -29% |
| Growth Correlation 5y | -81.4% |
| CAGR 5y | -30.53% |
| CAGR/Mean DD 5y | -0.51 |
| Sharpe Ratio 12m | 0.50 |
| Alpha | -67.58 |
| Beta | 0.20 |
| Volatility | 119.29% |
| Current Volume | 1.8k |
| Average Volume 20d | 4.7k |
What is the price of CCM stocks?
As of December 22, 2024, the stock is trading at USD 4.42 with a total of 1,785 shares traded.
Over the past week, the price has changed by -10.81%, over one month by +5.12%, over three months by -22.54% and over the past year by -58.74%.
As of December 22, 2024, the stock is trading at USD 4.42 with a total of 1,785 shares traded.
Over the past week, the price has changed by -10.81%, over one month by +5.12%, over three months by -22.54% and over the past year by -58.74%.
Is Concord Medical Services a good stock to buy?
No, based on ValueRay Fundamental Analyses, Concord Medical Services (NYSE:CCM) is currently (December 2024) a stock to sell. It has a ValueRay Fundamental Rating of -65.56 and therefor a negative outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of CCM as of December 2024 is 3.14. This means that CCM is currently overvalued and has a potential downside of -28.96%.
No, based on ValueRay Fundamental Analyses, Concord Medical Services (NYSE:CCM) is currently (December 2024) a stock to sell. It has a ValueRay Fundamental Rating of -65.56 and therefor a negative outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of CCM as of December 2024 is 3.14. This means that CCM is currently overvalued and has a potential downside of -28.96%.
Is CCM a buy, sell or hold?
Concord Medical Services has no consensus analysts rating.
Concord Medical Services has no consensus analysts rating.
What are the forecast for CCM stock price target?
According to ValueRays Forecast Model, CCM Concord Medical Services will be worth about 3.4 in December 2025. The stock is currently trading at 4.42. This means that the stock has a potential downside of -23.3%.
According to ValueRays Forecast Model, CCM Concord Medical Services will be worth about 3.4 in December 2025. The stock is currently trading at 4.42. This means that the stock has a potential downside of -23.3%.
| Issuer | Forecast | Upside |
|---|---|---|
| Wallstreet Target Price | 1.2 | -72.9% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 3.4 | -23.3% |